ASO Author Reflections: Identifying pCR After Neoadjuvant Chemotherapy: The Key to Treatment De-escalation in Breast Cancer
Ann Surg Oncol
.
2022 Dec;29(Suppl 3):570-571.
doi: 10.1245/s10434-021-10699-3.
Epub 2021 Aug 25.
Authors
David W Lim
1
2
3
,
Nicole J Look Hong
4
5
6
Affiliations
1
Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. David.Lim@wchospital.ca.
2
Department of Surgery, Women's College Hospital, Toronto, ON, Canada. David.Lim@wchospital.ca.
3
Division of General Surgery, Department of Surgery, University Health Network, Toronto, ON, Canada. David.Lim@wchospital.ca.
4
Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
5
Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute, Toronto, ON, Canada.
6
Division of Surgical Oncology, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada.
PMID:
34435298
DOI:
10.1245/s10434-021-10699-3
No abstract available
Publication types
Comment
MeSH terms
Breast
Breast Neoplasms* / drug therapy
Breast Neoplasms* / genetics
Female
Humans
Neoadjuvant Therapy*